Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.
Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs
Zogopoulos P, Gkorgkolis V, Venetikidis A, Sagris K, Vretakos G, Theocharis Sand Rologis D
Allergic rhinitis is an IgE-mediated inflammation of the nasal mucosa that is clinically expressed with sneezing, nasal congestion/pruritus and rhinorrhea, in any combination. With nearly 10%-20% of the global population suffering from allergic rhinitis, it is obvious that it affects significantly patient’s quality of life and productivity, as well as imposes a huge economic burden through associated healthcare costs. Current pharmacological treatment (H1- antihistamines, glucocorticosteroids, leukotriene antagonists, decongestants, anticholinergics), as well as allergen immunotherapy, usually fail to achieve complete remission of symptoms or cause treatment-related side-effects. Extensive clinical and experimental investigations over the last decades have shed light on the efficacy, as well as mechanisms of action of acupuncture treatment for allergic rhinitis. We present the available data, to date, which suggest that acupuncture should be part of the treatment algorithm for allergic rhinitis patients.